Skip to main content

Natesto FDA Approval History

Last updated by Judith Stewart, BPharm on March 2, 2021.

FDA Approved: Yes (First approved May 28, 2014)
Brand name: Natesto
Generic name: testosterone
Dosage form: Intranasal Gel
Previous Name: CompleoTRT
Company: Acerus Pharmaceuticals Corporation
Treatment for: Hypogonadism, Male

Natesto (testosterone) is a bioadhesive intranasal gel testosterone product for the treatment of male hypogonadism.

Development timeline for Natesto

May 29, 2014Approval FDA Approves Natesto (testosterone) Nasal Gel to Treat Men with Low Testosterone
Jul  9, 2013United States Food and Drug Administration Accepts Trimel's NDA for CompleoTRT

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.